Legend Biotech (LEGN) EBIT Margin (2019 - 2025)
Legend Biotech (LEGN) posted EBIT Margin of 6.43% for Q4 2025, up 59.69% on a QoQ basis from 15.96% in Q3 2025, and up 3609.0% year-over-year from 0.17% in Q4 2024.
Legend Biotech (LEGN) EBIT Margin (2019 - 2025) Analysis & Trends
Legend Biotech's EBIT Margin history runs 7 years deep, the most recent figure standing at 6.43% for Q4 2025.
- Quarterly EBIT Margin rose 3609.0% year-over-year to 6.43% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 28.91% (up 910.0% YoY) and the FY2025 annual result came in at 13.27%, up 3607.0% from the prior year.
- EBIT Margin was 6.43% for Q4 2025 at Legend Biotech, up from 15.96% in the prior quarter.
- Across five years, EBIT Margin topped out at 0.18% in Q4 2023 and bottomed at 1581.66% in Q2 2022.
- A 5-year average of 261.24% and a median of 59.85% in 2022 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2022 — EBIT Margin sank 72920 bps — and 2023, when it soared 130343 bps.
- Legend Biotech's EBIT Margin stood at 228.07% in 2021, then tumbled by 123 bps to 508.75% in 2022, then soared by 100 bps to 0.18% in 2023, then sank by 22914 bps to 42.52% in 2024, then surged by 85 bps to 6.43% in 2025.
- Business Quant data shows LEGN's EBIT Margin at 6.43% in Q4 2025, 15.96% in Q3 2025, and 50.98% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 30.35% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | -6.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.43% |
| Sep 30, 2025 | -15.96% |
| Jun 30, 2025 | -50.98% |
| Mar 31, 2025 | -53.42% |
| Dec 31, 2024 | -42.52% |
| Sep 30, 2024 | -43.92% |
| Jun 30, 2024 | -12.57% |
| Mar 31, 2024 | -69.44% |
| Dec 31, 2023 | -0.18% |
| Sep 30, 2023 | -37.73% |
| Jun 30, 2023 | -278.23% |
| Mar 31, 2023 | -294.09% |
| Dec 31, 2022 | -508.75% |
| Sep 30, 2022 | -341.46% |
| Jun 30, 2022 | -1,581.66% |
| Mar 31, 2022 | -66.29% |
| Dec 31, 2021 | -228.07% |
| Sep 30, 2021 | -740.19% |
| Jun 30, 2021 | -852.46% |
| Mar 31, 2021 | -0.41% |